Brief: Trevi Therapeutics Announces Positive Outcome From Sample Size Re-Estimation

Trevi Therapeutics

12/12/2024 12:46

Dec 12 (Reuters) - Trevi Therapeutics  TRVI.O :
    * TREVI THERAPEUTICS ANNOUNCES POSITIVE OUTCOME FROM SAMPLE
SIZE
RE-ESTIMATION RESULTING IN NO CHANGE TO THE CURRENT SAMPLE SIZE
FOR THE PHASE 2B CORAL TRIAL IN IDIOPATHIC PULMONARY FIBROSIS
PATIENTS WITH CHRONIC COUGH
    * TREVI THERAPEUTICS INC - TRIAL REACHES 75% ENROLLMENT,
TOPLINE
RESULTS EXPECTED IN H1 2025
    * TREVI THERAPEUTICS INC - SSRE RECOMMENDS CONTINUATION OF
CORAL
TRIAL AS PLANNED

Source text:  ID:nPn3LSkxka 
Further company coverage:  TRVI.O 

 ((Reuters.Briefs@thomsonreuters.com;))